Lantheus Holdings (LNTH) Current Deferred Revenue (2023 - 2026)
Lantheus Holdings' (LNTH) quarterly Current Deferred Revenue came in at $6.6 million in Q1 2026, down 5.56% on a QoQ basis from $7.0 million in Q4 2025.
Lantheus Holdings (LNTH) Current Deferred Revenue (2023 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 4 years of Current Deferred Revenue data on file, last reported at $6.6 million in Q1 2026.
- On a quarterly basis, Current Deferred Revenue changed N/A year-over-year to $6.6 million in Q1 2026; TTM through Mar 2026 was $6.6 million, a N/A change from a year earlier, with the FY2025 full-year figure at $7.0 million, up 382.65% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $6.6 million, down from $7.0 million in the prior quarter.
- Over the last five years, Current Deferred Revenue for LNTH reached as high as $7.0 million in Q4 2025 and fell as low as $1.4 million in Q4 2024.
- Historically, Current Deferred Revenue has averaged $4.1 million across 4 years, with a median of $4.0 million in 2023.
- Across the five-year window, Current Deferred Revenue fell 2.82% in 2024 and soared 382.65% in 2025, its largest moves.
- Year by year, Current Deferred Revenue stood at $1.5 million in 2023, then declined by 2.82% to $1.4 million in 2024, then surged by 382.65% to $7.0 million in 2025, then fell by 5.56% to $6.6 million in 2026.
- Per Business Quant data, the three most recent Current Deferred Revenue figures were $6.6 million in Q1 2026, $7.0 million in Q4 2025, and $1.4 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.60 Mn |
| Dec 31, 2025 | 6.98 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Dec 31, 2023 | 1.49 Mn |